you're reading...
Autoimmune Diseases, Rheumatoid Arthritis

Pfizer Arthritis Pill Prompts Safety Concerns

By Drew Armstrong

Pfizer Inc. (PFE) (PFE)’s experimental pill to treat rheumatoid arthritis, one of the company’s leading drug candidates, raised “serious safety concerns” in trials, U.S. regulators said today.

The pill, tofacitinib, carried increased risks of serious infections and malignancies, in particular a higher chance of lymphoma, Food and Drug Administration staff wrote. The agency released the report ahead of a May 9 meeting of FDA medical advisers who will review tofacitinib’s benefits and risks.

Read more.

Advertisements

Discussion

Trackbacks/Pingbacks

  1. Pingback: Rheumatoid Arthritis Aches & Pains « MEDCRUNCH - May 8, 2012

What do you think?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: